.png){kind=logo}
Global Health shares (NSE: MEDANTA) have been witnessing a good recovery, opening at ₹1,001.10 on Jan 21, 2025. It is down by a small margin from the previous close of ₹1,001.60. The stock has been highly volatile over the past few weeks, with a trading volume of 441,628 shares and a market capitalization of about ₹27,824 crores. The stock price has reached a high of ₹1,049.00 and a low of ₹1,001.10 during the last trading session.
Global Health share price as of 11.31 am on 21 Jan, 2025
On 21 January 2025, Global Health share price is up by approximately 3.5%. This came as a breather after witnessing four consecutive negative days. During this period of ascendance, the stock moved ahead of sector performance by 2.1%. The intraday high is also reported to be ₹1,036.85. Thus, revealing optimism in investor circles despite a broader decline of 5.23% over the last month.
Current technical analysis indicates that Global Health's stock is trading above its 5-day moving average. However, it is still below its 20-day, 50-day, 100-day, and 200-day moving averages. This positioning suggests mixed signals for traders as short-term momentum is improving. Although longer-term trends are bearish.
Bearish signals from the 5-day EMA crossover were observed on January 9, 2025. A historical average price decline of -7.61% within seven weeks following similar bearish signals over the last decade.
Global Health has shown stability in its financials despite the current market volatility. The company achieved a return on equity (ROE) of 16.45% for the year ended March 31, 2024. Thus, outperforming the five-year average of 11.08%. Trailing twelve months (TTM) earnings per share (EPS) is ₹14.16, up by 8.75% over the year.
Valuation statistics as of January 21, 2025:
Price-to-Earnings (P/E) Ratio: 73.16
Price-to-Book (P/B) Ratio: 9.13
Sector P/E Ratio: 93.36
The ratios indicate that the stock is relatively more expensive than the earnings and book value. Despite the high value, it is doing relatively better than most of its peers in the healthcare sector.
Despite the positive performance today, analysts have given a cautious outlook on Global Health's shares. Many analysts’ have suggested a ‘Sell’ call based on current market conditions. However, a broader analysis shows that among ten analysts covering the stock:
3 analysts recommend: Strong Buy
2 recommend: Buy
3 recommend: Hold
2 recommend: Sell
Analysts have placed an average target price of ₹1290 for Global Health Ltd. This implies a potential upside of about 28.81% from its recent trading price of ₹1001.50. This mixed sentiment reflects varying expectations about the company's future performance amidst fluctuating market condition.
Looking ahead, analysts predict that Earnings of Global Health will continue to grow around 19% per annum, with revenue growth set at around 14.5% per annum. The potential for this kind of growth is likely to present a strong case for share price appreciation in the long term.
Share price analysis at Global Health shows the company to be recovering from recent turbulence as of January 21, 2025. Short-term indicators seem positive after today's gains. There are mixed long-term trends with negative technical indicators and analyst recommendations as well. Thus, investors will need to factor in these variables against the robust financial performance of the company.
